SWEDISH ORPHAN BIOVITRUM AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 280.2 SEK | 0.00% |
|
-0.78% | +4.94% |
| May. 24 | Sobi North America Gets FDA Fast Track Designation for Rheumatic Disease Complication Treatment | DJ |
| May. 14 | Swedish Orphan Biovitrum AB Elects Zlatko Rihter as New Board Member | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 8.87B | ||||||
| 90.27B | ||||||
| 40.12B | ||||||
| 31.75B | ||||||
| 26.6B | ||||||
| 14.41B |
